key: cord-0748881-slz99mii
authors: Martínez-Amorós, Erika; Serra, Pilar; Bassa, Adriana; Palao, Diego J.; Cardoner, Narcís
title: Discontinuation of maintenance electroconvulsive therapy: lessons learned from the COVID-19 pandemic
date: 2021-07-27
journal: Rev Psiquiatr Salud Ment
DOI: 10.1016/j.rpsm.2021.07.005
sha: 4371af87f5c95b4c55f2957eaff8238a1c3bbf29
doc_id: 748881
cord_uid: slz99mii

nan

J o u r n a l P r e -p r o o f 3 particularly affected: the time between treatments has been prolonged 1 or fully discontinued in many hospitals. [3] [4] [5] [6] [7] Literature on the outcome of patients discontinuing M-ECT is limited, but the data suggest high rates of relapse (44-50%), especially in the first year after discontinuation. 8, 9 In our hospital, ECT was halted completely on March 18, 2020, mainly due to the reassignment of anesthesiologists to the intensive care units. Normal activity was not The inability to maintain ECT programs may significantly increase the risk of relapse, the rates of hospitalization, and also incurs high healthcare costs. Healthcare managers and providers should be reminded that ECT is an essential treatment. If access to ECT cannot be guaranteed in all settings, centralized care should be considered.

A Model for ethical triaging of electroconvulsive therapy patients during COVID-19 pandemic

Electroconvulsive Therapy During COVID-19-Times: Our Patients Cannot Wait

Electroconvulsive therapy protocol adaptation during the COVID-19 pandemic

Electroconvulsive Therapy Practice Changes in Older Individuals Due to COVID-19: Expert Consensus Statement

Electroconvulsive Therapy in a Time of Coronavirus Disease

The Other Victims of COVID-19: The Value of Electroconvulsive Therapy

One-year follow-up after discontinuing maintenance electroconvulsive therapy

Clinical outcome after discontinuation of maintenance Electroconvulsive Therapy. A retrospective follow-up study